Greg Zante - Insider Trading & Ownership

Entity
Individual
Location
C/O Sangamo Biosciences, Inc Ste A 100, Point Richmond Tech, 501 Canal Blvd,, Richmond, CA
Summary
The estimated net worth of Greg Zante is at least $25.5M dollars as of October 28, 2024. Greg Zante is the Chief Financial Officer of Viking Therapeutics, Inc. and owns shares of Viking Therapeutics, Inc. (VKTX) stock worth about $25.5M.
All Insider Reports
All Insider Reports

Ownership of Greg Zante

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VKTX Viking Therapeutics, Inc. Chief Financial Officer $25.5M -$16.3M -39% Oct 28, 2024

Insider Transactions Reported by Greg Zante:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.